Insiders · Profile

Brennan Daniel J.

EVP and CFO at Boston Scientific. Filing since 24 Feb 2016. CIK 0001595612

Company
Date
Role
Action
Shares
Amount
Of holding
19 Feb 2025
EVP and CFO
Sold on a plan
67,333
$7.09M
23.0%
18 Feb 2025
EVP and CFO
Sold on a plan
17,530
$1.83M
7.0%
12 Feb 2025
EVP and CFO
Sold on a plan
15,087
$1.59M
5.9%
3 Jan 2025
EVP and CFO
Sold on a plan
9,689
$870.64K
4.1%
23 May 2024
EVP and CFO
Sold on a plan
47,621
$3.58M
17.5%
22 May 2024
EVP and CFO
Sold on a plan
64,454
$4.89M
19.2%
20 Feb 2024
EVP and CFO
Sold at will
13,662
$899.78K
4.8%
2 Mar 2023
EVP and CFO
Sold, plan not stated
30,000
$1.40M
11.7%
1 Mar 2023
EVP and CFO
Sold, plan not stated
75,610
$3.53M
22.8%
15 Feb 2023
EVP and CFO
Sold, plan not stated
7,572
$356.93K
2.7%
2 Mar 2022
EVP and CFO
Sold, plan not stated
11,029
$485.65K
4.0%
22 Feb 2022
EVP and CFO
Sold, plan not stated
53,182
$2.27M
16.3%
16 Feb 2022
EVP and CFO
Sold, plan not stated
12,187
$532.58K
4.4%
15 Feb 2022
EVP and CFO
Sold, plan not stated
9,136
$397.14K
3.3%
3 Mar 2021
EVP and CFO
Sold, plan not stated
12,127
$469.18K
4.4%
2 Mar 2021
EVP and CFO
Sold, plan not stated
9,475
$368.03K
3.3%
23 Feb 2021
EVP and CFO
Sold, plan not stated
24,846
$974.70K
8.1%
5 Jan 2021
EVP and CFO
Sold, plan not stated
17,083
$603.41K
6.1%
13 Feb 2020
EVP and CFO
Sold, plan not stated
20,463
$860.04K
8.2%
2 Oct 2019
EVP and CFO
Sold, plan not stated
20,462
$807.04K
8.7%
14 Mar 2019
EVP and CFO
Sold, plan not stated
46,360
$1.86M
17.7%
4 Mar 2019
EVP and CFO
Sold, plan not stated
64,223
$2.62M
19.7%
14 Feb 2019
EVP and CFO
Sold, plan not stated
22,438
$887.91K
7.4%
19 Mar 2018
EVP and CFO
Sold, plan not stated
60,209
$1.68M
17.7%
11 Jul 2017
EVP and CFO
Sold, plan not stated
92,158
$2.53M
30.0%
25 Feb 2016
EVP and CFO
Sold, plan not stated
3,620
$63.28K
2.4%
24 Feb 2016
EVP and CFO
Sold, plan not stated
99,591
$1.71M
39.5%
27 decisions on file.